GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Dabomb Protein Biotech Corp (ROCO:6578) » Definitions » Additional Paid-In Capital

Dabomb Protein Biotech (ROCO:6578) Additional Paid-In Capital : NT$361.2 Mil(As of Mar. 2024)


View and export this data going back to 2016. Start your Free Trial

What is Dabomb Protein Biotech Additional Paid-In Capital?


Dabomb Protein Biotech's quarterly additional paid-in capital increased from Sep. 2023 (NT$325.5 Mil) to Dec. 2023 (NT$344.5 Mil) and increased from Dec. 2023 (NT$344.5 Mil) to Mar. 2024 (NT$361.2 Mil).

Dabomb Protein Biotech's annual additional paid-in capital increased from Dec. 2021 (NT$246.9 Mil) to Dec. 2022 (NT$286.3 Mil) and increased from Dec. 2022 (NT$286.3 Mil) to Dec. 2023 (NT$344.5 Mil).

Dabomb Protein Biotech Additional Paid-In Capital Historical Data

The historical data trend for Dabomb Protein Biotech's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Dabomb Protein Biotech Additional Paid-In Capital Chart

Dabomb Protein Biotech Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Additional Paid-In Capital
Get a 7-Day Free Trial Premium Member Only Premium Member Only 247.31 252.73 246.90 286.31 344.46

Dabomb Protein Biotech Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Additional Paid-In Capital Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 287.56 325.45 325.45 344.46 361.18

Dabomb Protein Biotech Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital=(Issue Price-Par Value)* Shares Outstanding (Diluted Average)

Dabomb Protein Biotech Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of Dabomb Protein Biotech's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

Dabomb Protein Biotech (ROCO:6578) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Dabomb Protein Biotech Corp (ROCO:6578) » Definitions » Additional Paid-In Capital
Comparable Companies
ROCO:6886 ROCO:4109 ROCO:2726 ROCO:1294 ROCO:2756 ROCO:6968 TPE:1220 ROCO:1271 TPE:1233 ROCO:6929 XSWX:NESN KHC GIS XPAR:BN SHSE:603288 NSE:NESTLEIND SZSE:300999 SHSE:600887 TSE:2802 LSE:ABF
Traded in Other Exchanges
N/A
Address
Number 52, Gongye 3rd Road, Annan District, Tainan, TWN, 709
Website
https://www.dabombprotein.com
Dabomb Protein Biotech Corp is a company specializing in antibiotic alternatives, and use postbiotics to boost immune strength and excel in innovative fermentation for improved plant protein utility. Their portfolio of products which include DBT-100 LS and DBT-100 HT , Liqui-TIDE bandage and LACTOTIDES HEALTH A+.

Dabomb Protein Biotech (ROCO:6578) Headlines

No Headlines